Abstract
Predictive modeling strategies are increasingly studied as a means to overcome clinical bottlenecks in the diagnostic classification of autism spectrum disorder. However, while some findings are promising in the light of diagnostic marker research, many of these approaches lack the scalability for adequate and effective translation to everyday clinical practice. In this study, our aim was to explore the use of objective computer vision video analysis of real-world autism diagnostic interviews in a clinical sample of children and adolescents to predict diagnosis. Specifically, we trained a support vector machine learning model on interpersonal synchrony data recorded in Autism Diagnostic Observation Schedule (ADOS) interviews of patient-clinician dyads. Our model was able to classify dyads involving an autistic patient (n=56) with a balanced accuracy of 63.4% against dyads including a patient with other psychiatric diagnoses (n=38). Further analyses revealed no significant associations between our classification metrics with clinical ratings. We argue that, given the above-chance performance of our classifier in a highly heterogeneous sample both in age and diagnosis, with few adjustments this highly scalable approach presents a viable route for future diagnostic marker research in autism.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study design, analysis, interpretation of data and writing was supported by Stiftung Irene (PhD scholarship awarded to JCK) and the German Research Council (Grant numbers 876/3-1 and FA 876/5-1, awarded to CFW). This research was supported by the Institute for Information & Communications Technology Promotion (ITTP) grant funded by the Korean government (MSIT) (No.2019-0-00330, Development of AI Technology for Early Screening of Infant/Child Autism Spectrum Disorders based on Cognition of the Psychological Behavior and Response).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study to use fully anonymized data collected retrospectively and prospectively were approved by the Institutional Review Board at Seoul National University Bundang Hospital (IRB no., B-1812-513-105; B-1912-580-304). Informed consent was obtained for the participant data collected prospectively from both participants and, in case the participant was a minor, their parent or legal guardian. A separate informed consent for the analysis of completely anonymized retrospective data was waived.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
8 Availability of data and materials
The datasets generated or analyzed during the study are not publicly available as the IRB approved the data to be used within the research team but could be available from the corresponding author on reasonable request. The preprocessing scripts used during this study are available under https://github.com/jckoe/SNU_ASDsync.git
